Current Controversies and Challenges in Brugada Syndrome

More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional ris...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Afik D Snir, Hariharan Raju
Formato: article
Lenguaje:EN
Publicado: Radcliffe Medical Media 2019
Materias:
Acceso en línea:https://doaj.org/article/924ef43354f64c3f9518a0efa09e1a0e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:924ef43354f64c3f9518a0efa09e1a0e
record_format dspace
spelling oai:doaj.org-article:924ef43354f64c3f9518a0efa09e1a0e2021-12-04T16:01:52ZCurrent Controversies and Challenges in Brugada Syndrome10.15420/ecr.2019.12.21758-37641758-3756https://doaj.org/article/924ef43354f64c3f9518a0efa09e1a0e2019-12-01T00:00:00Zhttps://www.ecrjournal.com/articles/Current-Controversies-Challenges-Brugada-Syndromehttps://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional risk modification strategies as well as our current pathophysiological understanding of the disease.Afik D SnirHariharan RajuRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 14, Iss 3, Pp 169-174 (2019)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Diseases of the circulatory (Cardiovascular) system
RC666-701
Afik D Snir
Hariharan Raju
Current Controversies and Challenges in Brugada Syndrome
description More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional risk modification strategies as well as our current pathophysiological understanding of the disease.
format article
author Afik D Snir
Hariharan Raju
author_facet Afik D Snir
Hariharan Raju
author_sort Afik D Snir
title Current Controversies and Challenges in Brugada Syndrome
title_short Current Controversies and Challenges in Brugada Syndrome
title_full Current Controversies and Challenges in Brugada Syndrome
title_fullStr Current Controversies and Challenges in Brugada Syndrome
title_full_unstemmed Current Controversies and Challenges in Brugada Syndrome
title_sort current controversies and challenges in brugada syndrome
publisher Radcliffe Medical Media
publishDate 2019
url https://doaj.org/article/924ef43354f64c3f9518a0efa09e1a0e
work_keys_str_mv AT afikdsnir currentcontroversiesandchallengesinbrugadasyndrome
AT hariharanraju currentcontroversiesandchallengesinbrugadasyndrome
_version_ 1718372749693419520